Wikidata

(Q34479624)

English

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

scientific article

In more languages

Statements

title
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11769764
retrieved
2 August 2017
publication date
1 December 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11769764
retrieved
2 August 2017
page(s)
1078-1079
1 reference
stated in
Europe PubMed Central
PubMed ID
11769764
retrieved
2 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34479624&oldid=1877396243"